Strong mucosal adjuvanticity of cholera toxin within lipid particles of a new multiple emulsion delivery system for oral immunization

被引:19
作者
Tomasi, M
Dertzbaugh, MT
Hearn, T
Hunter, RL
Elson, CO
机构
[1] UNIV ALABAMA,SCH MED,DIV GASTROENTEROL & HEPATOL,BIRMINGHAM,AL 35294
[2] USAMRIID,FREDERICK,MD
[3] CTR DIS CONTROL,ATLANTA,GA 30333
[4] EMORY UNIV,DEPT PATHOL,ATLANTA,GA 30322
关键词
mucosal adjuvanticity; cholera toxin; emulsion;
D O I
10.1002/eji.1830271036
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cholera toxin (CT) is an effective mucosal adjuvant but causes significant intestinal secretion which limits its usefulness. In the present study we developed a new multiple emulsion (ME) delivery system into which antigen and CT could be incorporated and asked whether CT would retain its mucosal adjuvanticity when sequestered within emulsion particles. ME were selectively taken up into Peyer's patches, and those containing antigen plus CT generated intestinal secretory IgA and serum IgG antibody responses in mice comparable quantitatively and qualitatively to those occurring after oral immunization with soluble antigen plus CT. The ME particles containing CT did not cause intestinal secretion. The adjuvanticity of CT within ME was due to the CT present in the inner aqueous phase of the ME and was lost if CT binding was blocked by pre-incubation with GM1 ganglioside. Proteins incorporated in ME were protected from external acid, protease, and bile. We conclude that CT sequestered in ME, although unable to bind to the epithelium and thus stimulate intestinal secretion, still retains its mucosal adjuvanticity. Thus, the ability of CT to bind to enterocytes is not obligatory for its mucosal adjuvanticity.
引用
收藏
页码:2720 / 2725
页数:6
相关论文
共 24 条
[1]   COMPARATIVE EFFECTIVENESS OF THE CHOLERA TOXIN-B SUBUNIT AND ALKALINE-PHOSPHATASE AS CARRIERS FOR ORAL VACCINES [J].
DERTZBAUGH, MT ;
ELSON, CO .
INFECTION AND IMMUNITY, 1993, 61 (01) :48-55
[2]   BIODEGRADABLE MICROSPHERES AS A VACCINE DELIVERY SYSTEM [J].
ELDRIDGE, JH ;
STAAS, JK ;
MEULBROEK, JA ;
MCGHEE, JR ;
TICE, TR ;
GILLEY, RM .
MOLECULAR IMMUNOLOGY, 1991, 28 (03) :287-294
[3]  
ELSON CO, 1995, FASEB J, V9, pA290
[4]  
ELSON CO, 1984, J IMMUNOL, V133, P2892
[5]   A LAVAGE TECHNIQUE ALLOWING REPEATED MEASUREMENT OF IGA ANTIBODY IN MOUSE INTESTINAL SECRETIONS [J].
ELSON, CO ;
EALDING, W ;
LEFKOWITZ, J .
JOURNAL OF IMMUNOLOGICAL METHODS, 1984, 67 (01) :101-108
[6]  
ELSON CO, 1994, HDB MUCOSAL IMMUNOLO, P391
[7]  
FINKELSTEIN RA, 1973, CRC CRIT R MICROBIOL, V2, P553
[8]  
HERBERT WJ, 1965, LANCET, V2, P771
[9]   ADJUVANT ACTIVITY OF NONIONIC BLOCK COPOLYMERS .4. EFFECT OF MOLECULAR-WEIGHT AND FORMULATION ON TITER AND ISOTYPE OF ANTIBODY [J].
HUNTER, R ;
OLSEN, M ;
BUYNITZKY, S .
VACCINE, 1991, 9 (04) :250-256
[10]  
HUNTER R, 1981, J IMMUNOL, V127, P1244